Harald Lahner Selected Research

Harald Lahner Research Topics

Disease

8	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2021 - 12/2011
6	Neoplasms (Cancer) 04/2021 - 03/2007
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020
3	Obesity 01/2010 - 11/2007
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2021 - 01/2021
2	Acromegaly 01/2019 - 08/2010
1	Sepsis (Septicemia) 01/2022
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2021
1	Hypothyroidism 12/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Neuroendocrine Carcinoma 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Disease Progression 10/2017
1	Vitamin D Deficiency 06/2017
1	Fatigue 03/2016
1	Infections 03/2016
1	Stomatitis 03/2016
1	Primitive Neuroectodermal Tumors (PNET) 02/2016
1	Graves Disease (Basedow Disease) 04/2011
1	Hematoma 04/2011
1	Hypocalcemia 04/2011
1	Thyroid Diseases (Thyroid Disease) 04/2011
1	Vocal Cord Paralysis 04/2011
1	Hypertension (High Blood Pressure) 08/2010
1	Diabetes Mellitus 08/2010
1	Cushing Syndrome 06/2010
1	Adenoma (Adenomas) 06/2010
1	Pituitary Diseases (Disease, Anterior Pituitary) 03/2010
1	Insulin Resistance 11/2007
1	Menstruation Disturbances 11/2007
1	Body Weight (Weight, Body) 11/2007
1	Anovulation 11/2007
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 11/2007
1	Acne Vulgaris 11/2007
1	Hyperandrogenism 11/2007
1	Overweight 11/2007
1	Hirsutism 03/2007
1	Leydig Cell Tumor 03/2007
1	Virilism (Virilization) 03/2007

Drug/Important Bio-Agent (IBA)

5	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2021 - 12/2011
4	Everolimus FDA Link 01/2018 - 02/2016
3	Ga(III)-DOTATOCIBA 04/2021 - 12/2011
3	Insulin (Novolin)FDA Link 01/2010 - 11/2007
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2021 - 12/2011
2	Edotreotide (SMT 487)IBA 04/2020 - 04/2020
2	Pharmaceutical PreparationsIBA 10/2017 - 03/2016
2	Testosterone (Sustanon)FDA Link 11/2007 - 03/2007
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Sunitinib (Sutent)FDA Link 12/2021
1	lanreotide (Somatuline)FDA Link 07/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2020
1	IpilimumabIBA 01/2020
1	NivolumabIBA 01/2020
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2019
1	Vitamin D FDA LinkGeneric 06/2017
1	TOR Serine-Threonine KinasesIBA 02/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2016
1	dactolisibIBA 02/2016
1	LigandsIBA 01/2013
1	gallium Ga 68 dotatateIBA 12/2011
1	HDL LipoproteinsIBA 08/2010
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2010
1	CholesterolIBA 08/2010
1	Insulin-Like Growth Factor I (IGF-1)IBA 08/2010
1	LDL Lipoproteins (beta Lipoproteins)IBA 08/2010
1	pegvisomant FDA LinkGeneric 08/2010
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2010
1	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2010
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 01/2010
1	Transcription Factors (Transcription Factor)IBA 01/2010
1	Glucose (Dextrose)FDA LinkGeneric 11/2007
1	Metformin (Glucophage)FDA LinkGeneric 11/2007
1	AndrogensIBA 03/2007

Therapy/Procedure

8	Therapeutics 01/2022 - 12/2011
1	Combined Modality Therapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 01/2020
1	Thyroidectomy 04/2011
1	Adrenalectomy 06/2010
1	Ovariectomy (Oophorectomy) 03/2007